GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ProText Mobility Inc (OTCPK:TXTM) » Definitions » Sloan Ratio %

ProText Mobility (ProText Mobility) Sloan Ratio % : 0.00% (As of Sep. 2014)


View and export this data going back to 2003. Start your Free Trial

What is ProText Mobility Sloan Ratio %?

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

ProText Mobility's Sloan Ratio for the quarter that ended in Sep. 2014 was 0.00%.

As of Sep. 2014, ProText Mobility has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.


ProText Mobility Sloan Ratio % Historical Data

The historical data trend for ProText Mobility's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ProText Mobility Sloan Ratio % Chart

ProText Mobility Annual Data
Trend Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
Sloan Ratio %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -481.90 -1,045.79 -1,187.39 - -

ProText Mobility Quarterly Data
Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14
Sloan Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of ProText Mobility's Sloan Ratio %

For the Biotechnology subindustry, ProText Mobility's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ProText Mobility's Sloan Ratio % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ProText Mobility's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where ProText Mobility's Sloan Ratio % falls into.



ProText Mobility Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

ProText Mobility's Sloan Ratio for the fiscal year that ended in Dec. 2013 is calculated as

Sloan Ratio=(Net Income (A: Dec. 2013 )-Cash Flow from Operations (A: Dec. 2013 )
-Cash Flow from Investing (A: Dec. 2013 ))/Total Assets (A: Dec. 2013 )
=(-1.447--0.366
-0)/0.005
=-21,620.00%

ProText Mobility's Sloan Ratio for the quarter that ended in Sep. 2014 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Sep. 2014 )
=(-1.743--0.706
-0)/0.02
=-5,185.00%

ProText Mobility's Net Income for the trailing twelve months (TTM) ended in Sep. 2014 was -0.322 (Dec. 2013 ) + -0.429 (Mar. 2014 ) + -0.698 (Jun. 2014 ) + -0.294 (Sep. 2014 ) = $-1.74 Mil.
ProText Mobility's Cash Flow from Operations for the trailing twelve months (TTM) ended in Sep. 2014 was -0.105 (Dec. 2013 ) + -0.156 (Mar. 2014 ) + -0.207 (Jun. 2014 ) + -0.238 (Sep. 2014 ) = $-0.71 Mil.
ProText Mobility's Cash Flow from Investing for the trailing twelve months (TTM) ended in Sep. 2014 was 0 (Dec. 2013 ) + 0 (Mar. 2014 ) + 0 (Jun. 2014 ) + 0 (Sep. 2014 ) = $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ProText Mobility  (OTCPK:TXTM) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Sep. 2014, ProText Mobility has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.


ProText Mobility Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of ProText Mobility's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


ProText Mobility (ProText Mobility) Business Description

Traded in Other Exchanges
N/A
Address
One West Las Olas Boulevard, Suite 500, Fort Lauderdale, FL, USA, 33301
ProText Mobility Inc is a Biotech Company developing a Hemp/CBD - Cannabis medicines platform for the legal cannabis industry, using proprietary live plant extraction processes & technologies. Protext has engaged in the research, testing, and development of bioavailable botanical products all-natural ingredients formulated for nutraceuticals and pharmaceutical applications through proprietary live plant extraction technology.
Executives
Peter Sealey director 37400 CENTRAL COURT, NEWARK CA 94560

ProText Mobility (ProText Mobility) Headlines

From GuruFocus